| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |